Michael Glover

3.3k total citations
17 papers, 221 citations indexed

About

Michael Glover is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Glover has authored 17 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Glover's work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer Genomics and Diagnostics (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). Michael Glover is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Cancer Genomics and Diagnostics (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). Michael Glover collaborates with scholars based in United States, United Kingdom and Sweden. Michael Glover's co-authors include Emad Mansoor, Sravanthi Parasa, Gregory S. Cooper, O Hudlická, Steven R. Garfin, Richard H. Rothman, Stuart Egginton, Robert E. Booth, Frederick A. Simeone and Linda M. McGrady and has published in prestigious journals such as Journal of Clinical Oncology, Spine and Cancer Discovery.

In The Last Decade

Michael Glover

15 papers receiving 214 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Glover United States 8 97 90 68 30 29 17 221
Okeefe L. Simmons United States 6 36 0.4× 71 0.8× 48 0.7× 20 0.7× 13 0.4× 9 438
Sertaç Ata Güler Türkiye 8 102 1.1× 62 0.7× 109 1.6× 6 0.2× 46 1.6× 39 262
Kush Gupta United States 8 78 0.8× 16 0.2× 106 1.6× 9 0.3× 50 1.7× 30 275
Kul Ranjan Singh India 9 69 0.7× 56 0.6× 64 0.9× 10 0.3× 38 1.3× 30 243
Elizabeth Gilmour United Kingdom 8 33 0.3× 42 0.5× 53 0.8× 6 0.2× 34 1.2× 12 281
A Poirier France 4 155 1.6× 24 0.3× 96 1.4× 8 0.3× 37 1.3× 12 292
Stefan Degenhardt Germany 9 51 0.5× 17 0.2× 55 0.8× 7 0.2× 47 1.6× 15 215
Sarah Keller United States 8 14 0.1× 81 0.9× 55 0.8× 18 0.6× 14 0.5× 13 330
Piergianni Biondi Italy 9 88 0.9× 110 1.2× 79 1.2× 6 0.2× 18 0.6× 12 299
Lianne Tile Canada 6 108 1.1× 40 0.4× 30 0.4× 5 0.2× 12 0.4× 12 322

Countries citing papers authored by Michael Glover

Since Specialization
Citations

This map shows the geographic impact of Michael Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Glover more than expected).

Fields of papers citing papers by Michael Glover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Glover. The network helps show where Michael Glover may publish in the future.

Co-authorship network of co-authors of Michael Glover

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Glover. A scholar is included among the top collaborators of Michael Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Glover. Michael Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Laliotis, George, Kevin Reyes, Beverly S. Mitchell, et al.. (2025). Association of tumor-informed ctDNA-based molecular residual disease (MRD) with clinical outcomes for upper tract urothelial cancer (UTUC).. Journal of Clinical Oncology. 43(16_suppl). 4565–4565. 1 indexed citations
2.
Glover, Michael, et al.. (2024). Case report: Dramatic impact of DNA next generation sequencing results using specific targeted therapies—ALK and PIK3CA. Frontiers in Oncology. 14. 1462930–1462930.
3.
Glover, Michael, et al.. (2024). Outcomes with neoadjuvant chemotherapy in bladder-preserving treatment for MIBC.. Journal of Clinical Oncology. 42(4_suppl). 577–577.
4.
Laliotis, George, Michael Glover, Christopher Hoimes, et al.. (2023). Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis.. Journal of Clinical Oncology. 41(16_suppl). 3050–3050. 3 indexed citations
5.
Glover, Michael, et al.. (2023). Toward Precision Perioperative Therapy in GI Malignancies. JCO Precision Oncology. 7(7). e2200381–e2200381. 1 indexed citations
6.
Desai, Aakash, Michael Glover, Gavin Hui, et al.. (2022). Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020. Cancer Investigation. 41(1). 43–47. 1 indexed citations
7.
Glover, Michael, Michelle Chiu, Gavin Hui, et al.. (2022). Patient-reported outcome measurement implementation in cancer survivors: a systematic review. Journal of Cancer Survivorship. 18(2). 223–244. 15 indexed citations
8.
Glover, Michael, et al.. (2022). Immunotherapy for Urothelial Carcinoma: Focus on Clinical Utility of Nivolumab. OncoTargets and Therapy. Volume 15. 1259–1269. 1 indexed citations
9.
Elkrief, Arielle, Julie Wu, Chinmay Jani, et al.. (2021). Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. Cancer Discovery. 12(2). 303–330. 23 indexed citations
10.
Glover, Michael, Gavin Hui, Philip Savage, et al.. (2021). Disparity of race reporting in US Food and Drug Administration drug approvals for urinary system cancers from 2006 to 2021. British Journal of Urology. 129(2). 168–170. 3 indexed citations
11.
Wu, Julie, Daniel H. Kwon, Michael Glover, et al.. (2020). Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California. JCO Oncology Practice. 17(3). e377–e385. 12 indexed citations
12.
13.
Glover, Michael, et al.. (2019). Epidemiology of Colorectal Cancer in Average Risk Adults 20–39 Years of Age: A Population-Based National Study. Digestive Diseases and Sciences. 64(12). 3602–3609. 67 indexed citations
14.
Glover, Michael, et al.. (2017). Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncology Letters. 14(4). 3927–3934. 17 indexed citations
15.
Inufusa, Akihiko, Howard S. An, Michael Glover, et al.. (1996). The Ideal Amount of Lumbar Foraminal Distraction for Pedicle Screw Instrumentation. Spine. 21(19). 2218–2223. 27 indexed citations
16.
Egginton, Stuart, O Hudlická, & Michael Glover. (1993). Fine structure of capillaries in ischaemic and non ischaemic rat striated muscle. Effect of torbafylline.. PubMed. 12(1). 33–44. 19 indexed citations
17.
Garfin, Steven R., Michael Glover, Robert E. Booth, Frederick A. Simeone, & Richard H. Rothman. (1988). Laminectomy. Journal of Spinal Disorders. 1(2). 116???133–116???133. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026